ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 339705 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 339705; 2) Community: the network communities that were significantly associated with the response to NSC 339705; 3) Molecule: the relationships between components within communities and NSC 339705; 4) MDR: the compounds that were significantly associated with the NSC 339705.

NSC Compound Enrichment Correlation
NSC 176324 5-Isoxazoleacetic acid, .alpha.-amino-3-chloro-4,5-dihydro-4-hydroxy-, (4R-(4.alpha.,5.beta.(S*)))- 0.0171490505199911 0.27998864
NSC 376265 Piperazine-1-carbothioic acid, 4-cycloheptyl-, [1-(2-pyridyl)ethylidene]hydrazide 0.0171490505199911 0.31736073
NSC 651315 Null 0.0171490505199911 0.058692926
NSC 732517 Dasatinib 0.0171490505199911 -0.10252313
NSC 745940 Null 0.0171490505199911 -0.16887531
NSC 762756 Null 0.0171490505199911 0.12738782
NSC 112758 Rubomycin 0.0171490505199913 0.34740197
NSC 16258 Null 0.0171490505199913 0.22380992
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.0171490505199913 0.57806979
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.0171490505199913 0.40649913
Total:46  Current:15    [First] [Prev] [Next] [Last]